See also this year's filing and all EDGAR filings for this company.
PDF Report 0001938046_2026_Mangoceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.4747413073092356, 'aggregate_val': 16089573, 'exp_sum': 30631712, 'exp_to_value': {'IntangibleAssets': 14232484, 'AssetsNonCurrent': 14542139, 'AssetsCurrent': 1547434, 'PropertyPlantAndEquipment': 1794, 'remainder_Assets': 307861}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001938046, Mangoceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 14,232,484 |
| 1 | AssetsNonCurrent | 14,542,139 |
| 2 | AssetsCurrent | 1,547,434 |
| 3 | PropertyPlantAndEquipment | 1,794 |
| 4 | remainder_Assets | -14,234,278 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 890,568 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 1,348,051 |
| 9 | CostOfGoodsAndServicesSold | 54,422 |
| 10 | GeneralAndAdministrativeExpense | 3,756,373 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 822,860 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 12,506,664 |
| 17 | remainder_Revenues | 456,021 |
| 18 | remainder_NetIncome | -2,611,106 |
| 19 | remainder_ComprehensiveNetIncome | -1,218 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,089,573 |
| 1 | Liabilities | 890,568 |
| 2 | Expenses | 18,488,370 |
| 3 | Revenues | 456,021 |
| 4 | StockholdersEquity | 15,199,005 |
| 5 | NetIncome | -20,643,455 |
| 6 | ComprehensiveNetIncome | -20,644,673 |
| 7 | BaseVar | 19,268,428 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.164 |
| 9 | EconomicCapitalRatio | 1.03 |
Edgar->Model Mapping
Feature Distribution
Change over Time
